Statement on miltefosine - Potential ocular disorders in patients treated with miltefosine for post-kala-azar dermal leishmaniasis (PKDL)
South Africa’s mRNA hub progress is foundation for self-reliance
Vaccine Manufacturing Workshop for SEAR & WPR
WHO launches new repository on urban health
Ensuring artificial intelligence (AI) technologies for health benefit older people
ACT-Accelerator calls for fair share-based financing of US$ 23 billion to end pandemic as global emergency in 2022
Frontline perspectives on enhancing commitment to quality health services
FIFA and WHO reiterate call on world to #ACTogether to end COVID-19 pandemic
